Nucleosides. XLIV. Long-range proton-fluorine spin-spin coupling in 5-fluoropyrimidine nucleosides.

PubWeight™: 0.82‹?›

🔗 View Article (PMID 5638306)

Published in J Am Chem Soc on January 31, 1968

Authors

R J Cushley, I Wempen, J J Fox

Articles by these authors

Setting events in applied behavior analysis: Toward a conceptual and methodological expansion. J Appl Behav Anal (1981) 3.49

Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides. J Med Chem (1979) 2.80

Differential activity of potential antiviral nucleoside analogs on herpes simplex virus-induced and human cellular thymidine kinases. Antimicrob Agents Chemother (1981) 2.34

2'-fluoro-5-iodo-aracytosine, a potent and selective anti-herpesvirus agent. Antimicrob Agents Chemother (1980) 1.96

Antileukemic effects of pseudoisocytidine, a new synthetic pyrimidine C-nucleoside. Cancer Res (1976) 1.44

Solitary toy play and time out: a family treatment package for children with aggressive and oppositional behavior. J Appl Behav Anal (1980) 1.33

Peer social initiations and the modification of social withdrawal: a review and future perspective. J Pediatr Psychol (1981) 1.30

Incorporation of metabolites of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine into deoxyribonucleic acid of neoplastic and normal mammalian tissues. Biochem Pharmacol (1982) 1.24

Stereochemistry of methyl group insertion in corrinoid biosynthesis. Determination of carbon isotope chirality by 13C nuclear magnetic resonance. J Am Chem Soc (1973) 1.23

Conformations of human apolipoprotein E(263-286) and E(267-289) in aqueous solutions of sodium dodecyl sulfate by CD and 1H NMR. Biochemistry (1996) 1.19

Effects of certain nucleoside analogues on human cytomegalovirus replication in vitro. J Gen Virol (1984) 1.15

Increasing social interactions of severely handicapped autistic children. J Autism Dev Disord (1987) 1.15

Nucleoside antibiotics. Prog Nucleic Acid Res Mol Biol (1966) 1.13

Distribution, metabolism, and excretion of 1-(2-fluoro-2-deoxy-beta-D- arabinofuranosyl)thymine and 1-(2-fluoro-2-deoxy-beta-D-arabinofuranosyl)-5- iodocytosine. Cancer Res (1983) 1.09

The plateau outward current in canine ventricle, sensitive to 4-aminopyridine, is a constitutive contributor to ventricular repolarization. Br J Pharmacol (2007) 1.08

Nucleosides. LX. Fluorocarbohydrates. XXII. Synthesis of 2-deoxy-2-fluoro-D-arabinose and 9-(2-deoxy-2-fluoro-alpha- and -beta-D-arabinofuranosyl)adenines. J Org Chem (1969) 1.06

Inhibitory effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on woodchuck hepatitis virus replication in chronically infected woodchucks. Antimicrob Agents Chemother (1990) 1.06

Nucleosides. 73. Ribosyl analogs of chloramphenicol. J Org Chem (1971) 1.05

Nucleosides. XXXIX. 2'-deoxy-2'-fluorocytidine, 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-4-iminopyrimidine, and related derivatives. J Org Chem (1967) 1.05

Radiological impact of the use of calcium hydroxylapatite dermal fillers. Clin Radiol (2009) 1.05

Biosynthesis of prodigiosin. Incorporation patterns of C-labeled alanine, proline, glycine, and serine elucidated by fourier transform nuclear magnetic resonance. J Am Chem Soc (1973) 1.04

Pharmacological disposition and metabolic fate of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in mice and rats. Cancer Res (1981) 1.01

A practical synthesis of 2-deoxy-2-fluoro-D-arabinofuranose derivatives. Carbohydr Res (1975) 1.01

Nucleosides. LXXIX. Facile base-catalyzed hydrogen isotope labeling at position 6 of pyrimidine nucleosides. J Am Chem Soc (1973) 1.01

Effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on duck hepatitis B virus DNA level in serum and liver of chronically infected ducks. J Med Virol (1992) 1.00

Carbon-13 Fourier transform nuclear magnetic resonance. 8. Role of steric and electric field effects in fatty acid spectra. J Org Chem (1974) 0.99

Nucleosides. 129. Synthesis of antiviral nucleosides: 5-alkenyl-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)uracils. J Med Chem (1984) 0.97

Conformation of human serum apolipoprotein A-I(166-185) in the presence of sodium dodecyl sulfate or dodecylphosphocholine by 1H-NMR and CD. Evidence for specific peptide-SDS interactions. Biochim Biophys Acta (1996) 0.97

Conformation of human apolipoprotein C-I in a lipid-mimetic environment determined by CD and NMR spectroscopy. Biochemistry (1999) 0.97

Activity of 1-(2'-fluoro-2'-deoxy-beta-D-arabinofuranosyl)thymine against herpes simplex virus in cell cultures and rabbit eyes. Antimicrob Agents Chemother (1983) 0.97

Selective inhibition of DNA replication in herpes simplex virus infected cells by 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine. J Biol Chem (1982) 0.95

Phase I evaluation of 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in immunosuppressed patients with herpesvirus infection. Cancer Res (1983) 0.95

Nucleosides. 78. Synthesis of some 6-substituted uracils and uridines by the Wittig reaction. J Org Chem (1972) 0.95

Evaluation of the antiherpetic activity of 2'-fluoro-5-iodo-ara-C in rabbit eyes and cell cultures. Invest Ophthalmol Vis Sci (1981) 0.95

Nucleosides. 133. Synthesis of 5-alkenyl-1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)cytosines and related pyrimidine nucleosides as potential antiviral agents. J Med Chem (1985) 0.94

Effects of group socialization procedures on the social interactions of preschool children. Res Dev Disabil (1988) 0.94

Nucleosides. 114. 5'-O-Glucuronides of 5-fluorouridine and 5-fluorocytidine. Masked precursors of anticancer nucleosides. J Med Chem (1981) 0.94

Nucleosides. 123. Synthesis of antiviral nucleosides: 5-substituted 1-(2-deoxy-2-halogeno-beta-D-arabinofuranosyl)cytosines and -uracils. Some structure-activity relationships. J Med Chem (1983) 0.93

Biochemical effects of 2'-fluoro-5-methyl-1-beta-D-arabinofuranosyluracil and 2'-fluoro-5-iodo-1-beta-D-arabinofuranosylcytosine in mouse leukemic cells sensitive and resistant to 1-beta-D-arabinofuranosylcytosine. Cancer Res (1982) 0.93

Phase I trial of 1-(2'-deoxy-2'-fluoro-1-beta-D-arabinofuranosyl)-5-methyluracil (FMAU). Cancer Treat Rep (1985) 0.93

The helix-hinge-helix structural motif in human apolipoprotein A-I determined by NMR spectroscopy. Biochemistry (1997) 0.92

Secondary structure of human apolipoprotein A-I(1-186) in lipid-mimetic solution. FEBS Lett (2001) 0.92

Synthesis and biological effects of 2'-fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil. Antimicrob Agents Chemother (1987) 0.92

Nucleosides. 136. Synthesis and antiviral effects of several 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-alkyluracils. Some structure-activity relationships. J Med Chem (1986) 0.91

Activities of 1-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and its metabolites against herpes simplex virus types 1 and 2 in cell culture and in mice infected intracerebrally with herpes simplex virus type 2. Antimicrob Agents Chemother (1986) 0.91

Chronic intrauterine pulmonary hypertension alters endothelin receptor activity in the ovine fetal lung. Pediatr Res (1996) 0.89

A deuterium NMR study of labelled n-alkanol anesthetics in a model membrane. Chem Phys Lipids (1986) 0.89

Studies on almond emulsin beta-D-glucosidase. II. Kinetic evidence for independent glucosidase and galactosidase sites. Biochim Biophys Acta (1977) 0.89

Incorporation and metabolism of 2'-fluoro-5-substituted arabinosyl pyrimidines and their selective inhibition of viral DNA synthesis in herpes simplex virus type 1 (HSV-1)-infected and mock-infected Vero cells. Antiviral Res (1988) 0.89

Inhibition of simian varicella virus infection of monkeys by 1-(2-deoxy-2- fluoro-1-beta-D-arabinofuranosyl)-5-ethyluracil (FEAU) and synergistic effects of combination with human recombinant interferon-beta. Antiviral Res (1990) 0.88

Nucleosides. 58. Transformations of pyrimidine nucleosides in alkaline media. 3. The conversion of 5-halogenouridines into imidazoline and barbituric acid nucleosides. J Org Chem (1969) 0.88

Conformation of two peptides corresponding to human apolipoprotein C-I residues 7-24 and 35-53 in the presence of sodium dodecyl sulfate by CD and NMR spectroscopy. Biochemistry (1995) 0.87

Nucleosides. 48. Synthesis of 1-(5-deoxy-beta-D-arabinosyl)cytosine and related compounds. J Med Chem (1968) 0.87

Nucleosides. LII. Transformations of pyrimidine nucleosides in alkaline media. I. The conversion of 5-halogenoarabinosyluracils into imidazoline nucleosides. J Org Chem (1968) 0.87

Metabolic competition studies of 2'-fluoro-5-iodo-1-beta-d-arabinofuranosylcytosine in vero cells and herpes simplex type 1-infected vero cells. Mol Pharmacol (1984) 0.86

Deuterium NMR study of the effect of n-alkanol anesthetics on a model membrane system. Biochim Biophys Acta (1985) 0.86

Surface diffusion in human serum lipoproteins. Biochem Biophys Res Commun (1987) 0.85

Nucleosides. 104. Synthesis of 4-amino-5-(D-ribofuranosyl)pyrimidine C-nucleosides from 2-(2,3-O-isopropylidene-5-O-trityl-D-ribofuranosyl)acetonitrile. J Org Chem (1977) 0.85

Biosynthesis of corrins. II. Incorporation of 13C-labeled substrates in vitamins B12. J Am Chem Soc (1974) 0.85

Biotransformation and elimination of [2-14C]-1-(2-deoxy-2'-fluoro-beta-D -arabinofuranosyl)-5-iodocytosine in immunosuppressed patients with herpesvirus infections. Antimicrob Agents Chemother (1985) 0.85

Nucleosides. CXXXV. Synthesis of some 9-(2-deoxy-2-fluoro-beta-D-arabinofuranosyl)-9H-purines and their biological activities. Chem Pharm Bull (Tokyo) (1989) 0.84

Nucleosides. XLVII. Synthesis of some N4-substituted derivarives of 1-beta-D-arabinofuranosylcytosine and -5-fluorocytosine. J Med Chem (1968) 0.84

Nucleosides. LXXVI. A synthesis of a carbon-carbon bridged pyrimidine cyclonucleoside. J Org Chem (1972) 0.84

Studies on almond emulsin beta-D-glucosidase. I. Isolation and characterization of a bifunctional isozyme. Biochim Biophys Acta (1977) 0.83

Nucleosides XXXVI. Transformation of arabinopyrimidine nucleosides. Tetrahedron Lett (1966) 0.83

Structure of a biologically active fragment of human serum apolipoprotein C-II in the presence of sodium dodecyl sulfate and dodecylphosphocholine. Biochim Biophys Acta (2000) 0.83

Diagnostic imaging of herpes simplex virus encephalitis using a radiolabeled antiviral drug: autoradiographic assessment in an animal model. Ann Neurol (1984) 0.82

Quantitative autoradiographic mapping of herpes simplex virus encephalitis with a radiolabeled antiviral drug. Science (1982) 0.82

Carbon-13 nuclear magnetic resonance study of spin labelled cholesteryl ester in model membranes. Chem Phys Lipids (1983) 0.82

Electric field effects in the 13C nuclear magnetic resonance spectra of unsaturated fatty acids. A potential tool for conformational analysis. J Am Chem Soc (1973) 0.82

Sequence-specific 1H NMR resonance assignments and secondary structure of human apolipoprotein C-I in the presence of sodium dodecyl sulfate. Biochem Cell Biol (1998) 0.82

Dipyridamole, a cGMP phosphodiesterase inhibitor, causes pulmonary vasodilation in the ovine fetus. Am J Physiol (1995) 0.82

ESR studies on the orientation of cholesteryl ester in phosphatidylcholine multilayers. Biochim Biophys Acta (1979) 0.82

Insoluble complex formation between low density lipoprotein and heparin. A 31P-NMR study. Chem Phys Lipids (1990) 0.81

Nucleosides. 98. Direct introduction of an acetamido group into the sugar moiety of nucleoside epoxides. J Org Chem (1976) 0.81

Effect of histocompatibility factors on pulmonary retention of indium-111-labeled granulocytes. Am J Hematol (1990) 0.81

Deuterium NMR study of the interaction of alpha-tocopherol with a phospholipid model membrane. Biochemistry (1986) 0.81

Total synthesis of Gougerotin. J Am Chem Soc (1972) 0.81

The use of sodium dodecyl sulfate to model the apolipoprotein environment. Evidence for peptide-SDS complexes using pulsed-field-gradient NMR spectroscopy. Biochim Biophys Acta (1998) 0.81

Analogs of 1-beta-D-arabinofuranosylcytosine. Studies on mechanisms of action in Burkitt's cell culture and mouse leukemia, and in vitro deamination studies. Biochem Pharmacol (1967) 0.80

Dipyridamole potentiates pulmonary vasodilation induced by acetylcholine and nitric oxide in the ovine fetus. Am J Respir Crit Care Med (1998) 0.80

Kinetics and substrate specificity of human and canine cytidine deaminase. Biochem Pharmacol (1986) 0.80

Deuterium magnetic resonance study of cholesteryl esters in membranes. Biochemistry (1979) 0.80

Inhibitors of protein synthesis. 4. Studies on the structure-activity relationship of gougerotin and some of its analogs. J Med Chem (1975) 0.80

Comparison of 2'-fluoro-arabinosyl pyrimidine nucleosides and 1-beta-D-arabinofuranosylcytosine on immunological parameters in vitro. Int J Immunopharmacol (1983) 0.80

Synthesis and biological activities of 5-deaza analogues of aminopterin and folic acid. J Med Chem (1986) 0.80

Activity of 2-fluoro-5-methylarabinofuranosyluracil against mouse leukemias sensitive to and resistant to 1-beta-D-arabinofuranosylcytosine. Cancer Res (1982) 0.80

Conformational studies of the N-terminal lipid-associating domain of human apolipoprotein C-I by CD and 1H NMR spectroscopy. Protein Sci (1997) 0.80

Nucleosides. 100. General synthesis of pyrimidine C-5 cucleosides related to pseudouridine. Synthesis of 5-(beta-D-ribofuranosyl) isocytosine (pseudoisocytidine),5-(beta-D-ribofuranosyl)-2-thiouracil(2-thiopseudouridine) and 5-(beta-D-ribofuranosyl)uracil(pseudouridine). J Org Chem (1976) 0.79

Nucleosides. XXIX. 1-beta-D-arabinofuranosyl-5-fluorocytosine and related arabino nucleosides. J Med Chem (1966) 0.79

Nucleosides. XXXVII. 5,6-substituted 5-fluorodihydropyrimidines and their 2'-deoxyribonucleosides. J Med Chem (1967) 0.79

Conformational studies of an amphipathic peptide corresponding to human apolipoprotein A-II residues 18-30 with a C-terminal lipid binding motif EWLNS. Int J Pept Protein Res (1996) 0.79

Infrared spectroscopy of human apolipoprotein fragments in SDS/D2O: relative lipid-binding affinities and a novel amide I assignment. Biochemistry (1997) 0.79

Nucleosides. LIV. On the mechanism of certain anhydronucleosides reactions. Chem Pharm Bull (Tokyo) (1969) 0.78

Deuterium magnetic resonance of selectively deuterated cholesteryl esters in phosphatidylcholine vesicles. Biochemistry (1980) 0.78